Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Distribute Nonlinear Dynamics Proteomics Software

NEW YORK, July 11 - PerkinElmer has agreed to non-exclusively distribute Nonlinear Dynamics' software for automating the analysis of proteins in 2D gel electrophoresis experiments, the companies said Wednesday.

PerkinElmer, based in Boston, has integrated the software platform, called Progenesis, into its ProXpress imaging system for analyzing proteins in 2D gel experiments, and will distribute the software worldwide. Financial details were not disclosed.

The agreement strengthens PerkinElmer's position in the $1.5 billion proteomics market, said John Engel, president of PerkinElmer Life Sciences, in a statement.

Nonlinear Dynamics, based in Newcastle, UK, has specialized in creating software for electrophoresis analysis over its ten years in existence. The company also has an agreement with Hitachi subsidiary MiraiBio to distribute earlier versions of Nonlinear Dynamics' software.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.